HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 604 filers reported holding HORIZON THERAPEUTICS PUB L in Q4 2021. The put-call ratio across all filers is 0.78 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $46,276 | +12.5% | 400 | 0.0% | 0.01% | +20.0% |
| Q2 2023 | $41,140 | -5.8% | 400 | 0.0% | 0.01% | -16.7% |
| Q1 2023 | $43,656 | -4.1% | 400 | 0.0% | 0.01% | 0.0% |
| Q4 2022 | $45,520 | +82.1% | 400 | 0.0% | 0.01% | +50.0% |
| Q3 2022 | $25,000 | -21.9% | 400 | 0.0% | 0.00% | -20.0% |
| Q2 2022 | $32,000 | -23.8% | 400 | 0.0% | 0.01% | -16.7% |
| Q1 2022 | $42,000 | -2.3% | 400 | 0.0% | 0.01% | +20.0% |
| Q4 2021 | $43,000 | -2.3% | 400 | 0.0% | 0.01% | -16.7% |
| Q3 2021 | $44,000 | +18.9% | 400 | 0.0% | 0.01% | +20.0% |
| Q2 2021 | $37,000 | 0.0% | 400 | 0.0% | 0.01% | 0.0% |
| Q1 2021 | $37,000 | +27.6% | 400 | 0.0% | 0.01% | 0.0% |
| Q4 2020 | $29,000 | -6.5% | 400 | 0.0% | 0.01% | -16.7% |
| Q3 2020 | $31,000 | +40.9% | 400 | 0.0% | 0.01% | +20.0% |
| Q2 2020 | $22,000 | +83.3% | 400 | 0.0% | 0.01% | +66.7% |
| Q1 2020 | $12,000 | -14.3% | 400 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $14,000 | +27.3% | 400 | 0.0% | 0.00% | +50.0% |
| Q3 2019 | $11,000 | +10.0% | 400 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $10,000 | – | 400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
| Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
| Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
| 1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
| Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
| Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
| HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
| Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
| Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
| PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |